hydralazine has been researched along with ACTH-Producing Pituitary Adenoma in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yan, Y | 1 |
| Wang, C | 1 |
| Lu, Y | 1 |
| Gong, H | 1 |
| Wu, Z | 1 |
| Ma, X | 1 |
| Li, H | 1 |
| Wang, B | 1 |
| Zhang, X | 1 |
1 other study available for hydralazine and ACTH-Producing Pituitary Adenoma
| Article | Year |
|---|---|
Mineralocorticoid receptor antagonism protects the aorta from vascular smooth muscle cell proliferation and collagen deposition in a rat model of adrenal aldosterone-producing adenoma.
Topics: ACTH-Secreting Pituitary Adenoma; Aldosterone; Animals; Antihypertensive Agents; Aorta; Cell Prolife | 2018 |